Nasdaq

Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on lower revenues when Sage Therapeutics, Inc. (SAGE) reports results for the quarter ended December 2024. While this widely-known consensus ...
Nasdaq

Sage Therapeutics (SAGE) Down 17.1% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Sage Therapeutics, Inc. (SAGE). Shares have lost about 17.1% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Investors Should Be Encouraged By Sage Group's (LON:SGE) Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term?
Business Insider

Analysts Have Conflicting Sentiments on These Healthcare Companies: Biogen (BIIB), SAGE Therapeutics (SAGE) and Karyopharm Therapeutics (KPTI)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Biogen (BIIB – Research Report), SAGE Therapeutics (SAGE – Research Report) and Karyopharm Therapeutics ...
Seeking Alpha

Sage Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (SAGE), today announced that it will host a live webcast on Tuesday, February 11, 2025 at 4:30 p.m. ET to review fourth quarter and full ...